Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy
- PMID: 11174708
- DOI: 10.1067/msy.2001.110221
Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy
Abstract
Background: Resection of the portal/superior mesenteric vein (PV/SMV) during pancreatoduodenectomy (PD) is disputed. Although morbidity and mortality are acceptable, survival is limited after PV/SMV resection. In this study, we evaluate the effect of PV/SMV resection.
Methods: Between 1992 and 1998, there were 215 consecutive patients who underwent PD for malignant disease. Thirty-four patients underwent a PV/SMV resection. Resection was only performed when minimal venous ingrowth was found perioperatively. Surgical techniques, perioperative parameters, and survival were analyzed.
Results: The percentage of PV/SMV resections was 16%. Extensive (segment) resections were performed in 6 patients. The median blood loss was 1.8 L and resection margins were microscopically tumor free in 41% of the patients. The median hospital stay was 15 days, and mortality was 0%. Median survival after PV/SMV resection for pancreatic adenocarcinoma was 14 months.
Conclusions: Limited PV/SMV resection for perioperatively encountered minimal venous ingrowth during PD can be performed safely without increased morbidity and mortality but also results in a high frequency of tumor-positive resection margins.
Similar articles
-
Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.Pancreas. 2012 Jan;41(1):102-6. doi: 10.1097/MPA.0b013e318221c595. Pancreas. 2012. PMID: 21775914
-
Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.Surgery. 2009 Apr;145(4):417-25. doi: 10.1016/j.surg.2008.12.009. Epub 2009 Feb 23. Surgery. 2009. PMID: 19303991
-
Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.J Surg Oncol. 2013 Mar;107(4):414-21. doi: 10.1002/jso.23229. Epub 2012 Aug 6. J Surg Oncol. 2013. PMID: 22886567
-
Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):130-4. Hepatobiliary Pancreat Dis Int. 2005. PMID: 15730937 Review.
-
Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.Eur J Surg Oncol. 2014 Apr;40(4):371-8. doi: 10.1016/j.ejso.2014.01.010. Epub 2014 Feb 7. Eur J Surg Oncol. 2014. PMID: 24560302 Review.
Cited by
-
Surgical resection versus palliative chemoradiotherapy for the management of pancreatic cancer with local venous invasion: a decision analysis.J Gastrointest Surg. 2009 Jan;13(1):26-34. doi: 10.1007/s11605-008-0648-y. Epub 2008 Oct 23. J Gastrointest Surg. 2009. PMID: 18946644
-
Value of regional lymphadenectomy in pancreatic cancer.HPB (Oxford). 2005;7(2):87-92. doi: 10.1080/13651820510028855. HPB (Oxford). 2005. PMID: 18333169 Free PMC article.
-
Acute pancreatitis in patients with pancreatic cancer: Timing of surgery and survival duration.Medicine (Baltimore). 2017 Jan;96(3):e5908. doi: 10.1097/MD.0000000000005908. Medicine (Baltimore). 2017. PMID: 28099352 Free PMC article.
-
Pancreaticoduodenectomy with en bloc portal vein resection for pancreatic carcinoma with suspected portal vein involvement.World J Surg. 2004 Jun;28(6):602-8. doi: 10.1007/s00268-004-7250-6. World J Surg. 2004. PMID: 15366753
-
An innovative option for venous reconstruction after pancreaticoduodenectomy: the left renal vein.J Gastrointest Surg. 2007 Apr;11(4):425-31. doi: 10.1007/s11605-007-0131-1. J Gastrointest Surg. 2007. PMID: 17436125 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical